Biotechnology

Filter

Current filters:

None

Popular Filters

2301 to 2325 of 2516 results

Human Genome Sciences sets July 16 deadline for takeover bids

18-06-2012

In the latest update on UK pharma giant GlaxoSmithKline's (LSE: GSK) hostile takeover attempts for Human…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Second collaboration in Alzheimer's disease for Genentech and AC Immune

18-06-2012

Switzerland-based biopharma company AC Immune said this morning that it has entered into a second exclusive…

AC ImmuneBiotechnologycrenezumabGenentechLicensingNeurologicalPharmaceuticalResearchRoche

Ophthotech's Fovista tops Lucentis in wet AMD

15-06-2012

Privately-held US biotech firm Ophthotech Corp has announced results from the first clinical trial to…

BiotechnologyFovistaLucentisOphthalmicsOphthotechResearch

Osiris gets second approval for Prochymal, in New Zealand

15-06-2012

USA-based Osiris Therapeutics (Nasdaq: OSIR) has received a second approval to market its first-in-class…

Asia-PacificBiotechnologyImmunologicalsOsiris TherapeuticsProchymalRegulation

ERYTECH Pharma gains EU orphan designation for Enhoxy

14-06-2012

French late-stage biopharma company ERYTECH Pharma says that the Committee for Orphan Medicinal Products…

BiotechnologyEnhoxyErytech PharmaEuropeRare diseasesRegulation

Australia's PIC reports to Ministers on treatment and reimbursement of similar biologics

14-06-2012

The Australian Pharmaceuticals Industry Council (PIC), with industry group members AusBiotech, Medicines…

Asia-PacificBiotechnologyGenericsPharmaceuticalPricingRegulation

Value of new cancer medicines to patients evolve overtime, PhRMA report shows

13-06-2012

Following Food and Drug Administration approval of a new cancer medicine, it often takes years of additional…

BiotechnologyNorth AmericaOncologyPharmaceuticalRegulationResearch

Pharming considers options, including a sale of the company

13-06-2012

Netherland-based biotech company Pharming Group (NYSE Euronext: PHARM) yesterday revealed that it is…

BiotechnologyLicensingMergers & AcquisitionsPharmingRare diseasesResearchRuconest

Indian drugmakers group inks deal with DuBiotech

12-06-2012

The Indian Drug Manufacturers' Association (IDMA) has signed a memorandum of understanding with Dubai…

Asia-PacificBiotechnologyResearchRest of the World

Genzyme files multiple sclerosis drug Lemtrada with FDA and EMA

12-06-2012

French drug major Sanofi (Euronext: SAN) subsidiary Genzyme revealed this morning that it has submitted…

BayerBiotechnologyEuropeGenzymeLemtradaNeurologicalNorth AmericaPharmaceuticalRegulationSanofi

UK's NICE takes second look at Amgen's Xgeva

12-06-2012

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) today launched a second…

AmgenBiotechnologyEuropeOncologyPricingRegulationXgeva

More guidelines needed to grow regenerative medicine market, report finds

11-06-2012

Standardized research guidelines are needed to control and encourage the development of gene therapy…

BiotechnologyFinancialGlobalPoliticsRegulationResearch

German model for assessment of new medicines slammed by EU pharma leaders

11-06-2012

Leading pharmaceutical companies in Europe, represented in the European Federation of Pharmaceutical…

BiotechnologyEuropePharmaceuticalPoliticsPricingRegulation

Business in Japan versus to Japan, by P Reed Maurer

11-06-2012

A pharmaceutical company without a presence in Japan but with a hot new product ready for Phase III clinical…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

FDA backs Roche's personalized breast cancer therapy Perjeta

11-06-2012

The US Food and Drug Administration on Friday approved Swiss drug major Roche (ROG: SIX) subsidiary Genentech's…

BiotechnologyGenentechNorth AmericaOncologyPerjetapertuzumabPharmaceuticalRegulationRoche

Amgen's Sensipar/Mimpara fails to meet endpoint in CV events for dialysis patients

11-06-2012

Amgen (Nasdaq: AMGN), the world's largest independent biotech company, announced top-line results on…

AmgenBiotechnologyCardio-vascularMimparaNephrology and HepatologyResearchSensipar

1,000th designation of an orphan medicinal product in EU

10-06-2012

According to a European Commission statement, over 30 million European citizens suffer from a rare disease.…

BiotechnologyEuropePharmaceuticalRare diseasesRegulation

Nearly a-quarter of European countries do not provide access to biologics for arthritis

08-06-2012

Data from a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism…

Anti-Arthritics/RheumaticsBiotechnologyEuropeMarkets & MarketingPricing

Merck KGaA collaborates with Dr Reddy's on biosimilars

07-06-2012

With the aim of capitalizing on the batch of patent expires for blockbuster biotechnology-based drugs…

BiotechnologyDr Reddy's LaboratoriesGenericsMarkets & MarketingMerck KGaAMerck SeronoOncologyResearch

KYTHERA Biopharma gets $33.3 million in payments from Bayer

07-06-2012

Privately-held US biotech firm KYTHERA Biopharmaceuticals says it has received a $15.8 million payment…

BayerBiotechnologyFinancialKYTHERA BiopharmaceuticalsLicensingPharmaceuticalResearch

Reimbursement outlook for DMT Alzheimer's therapies in Europe

06-06-2012

Emerging potentially disease-modifying therapies (DMTs) for Alzheimer's disease will likely be reimbursed…

BiotechnologyEuropeMarkets & MarketingNeurologicalPharmaceuticalPricing

UK pharma industry head fears for future of UK medical research

06-06-2012

The UK government is too focused on encouraging "breakthrough drugs" at the expense of significant gains…

BiotechnologyEuropePharmaceuticalPoliticsPricingResearch

2301 to 2325 of 2516 results

COMPANY SPOTLIGHT

Menarini

Back to top